Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595254 · ClinicalTrials.gov registry record · NA
Digital Cognitive Behavior Therapy Program for Suicide Prevention
A NA study, sponsored by Montana State University.
- Completed
- Registry status
- NA
- Development phase
- 725
- Enrollment target
NCT03595254 is a NA study that has completed, run by Montana State University. The registered enrollment target is 725 participants.
The verdict
NCT03595254, a NA study, has completed, sponsored by Montana State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 725 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participants will be provided the program immediately upon enrolling
Interventions
- BEHAVIORAL Thrive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 725 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2020-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03595254
The ClinicalTrials.gov registry entry for NCT03595254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 725 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montana State University, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thrive is the first listed.
NCT03595254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03595254 about?
NCT03595254 is a clinical study titled "Digital Cognitive Behavior Therapy Program for Suicide Prevention". This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participant...
What is the current status of trial NCT03595254?
This trial is currently completed. It is a NA study. The enrollment target is 725 participants. The study started on 2018-11-16. Estimated completion is 2020-04-08.
What interventions are being tested in trial NCT03595254?
The interventions under investigation include: Thrive (BEHAVIORAL).
Who is sponsoring clinical trial NCT03595254?
This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.